AP2α alters the transcriptional activity and stability of p53

Oncogene

Volumn 25, Issue 15, 2006, Pages 2148-2159

  Stabach, P R ^a   Thiyagarajan, M M ^a   Woodfield, G W ^a,b   Weigel, R J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

AP 2; AP2 ; P21; P53; Stability; Transcription

Indexed keywords

PROTEIN P21; PROTEIN P53; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ALLELE; ALPHA CHAIN; AMINO ACID SEQUENCE; ARTICLE; ASSAY; BINDING SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE INDUCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; RADIATION; REPORTER GENE; TRANSCRIPTION INITIATION; WILD TYPE; BREAST TUMOR; CELL CULTURE; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; LIVER TUMOR; METABOLISM; PATHOLOGY; PROTEIN BINDING; TRANSACTIVATION;

BREAST NEOPLASMS; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; IMMUNOPRECIPITATION; LIVER NEOPLASMS; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645752099     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209250     Document Type: Article

References (54)

1. Anttila MA, Kellokoski JK, Moisio KI, Mitchell PJ, Saarikoski S, Syrjanen K et al. (2000). Br J Cancer 82: 1974-1983.
2. Astrom A, Pettersson U, Voorhees JJ. (1992). J Biol Chem 267: 25251-25255.
3. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, Williams T. (2002). Development 129: 2733-2747.
4. Baldi A, Santini D, Battista T, Dragonetti E, Ferranti G, Petitti T et al. (2001). J Cell Biochem 83: 364-372.
5. Bar-Eli M. (1999). Cancer Metast Rev 18: 377-385.
6. Bar-Eli M. (2001). Pigment Cell Res 14: 78-85.
7. Batsche E, Muchardt C, Behrens J, Hurst HC, Cremisi C. (1998). Mol Cell Biol 18: 3647-3658.
8. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC. (1996). Oncogene 13: 1701-1707.
9. Bosher JM, Williams T, Hurst HC. (1995). Proc Natl Acad Sci USA 92: 744-747.
10. Brokx RD, Bolewska-Pedyczak E, Gariepy J. (2003). J Biol Chem 278: 2327-2332 Epub 2002 Nov 13.
11. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Science 282: 1497-1501.
12. Buschmann T, Lin Y, Aithmitti N, Fuchs SY, Lu H, Resnick-Silverman L et al. (2001). J Biol Chem 276: 13852-13857 Epub 2001 Feb 1.
13. Chene P. (2001). Oncogene 20: 2611-2617.
14. deConinck EC, McPherson LA, Weigel RJ. (1995). Mol Cell Biol 15: 2191-2196.
15. Doerksen LF, Bhattacharya A, Kannan P, Pratt D, Tainsky MA. (1996). Nucleic Acids Res 24: 2849-2856.
16. Feng W, Williams T. (2003). Mol Cell Neurosci 24: 460-475.
17. Gee JM, Robertson JF, Ellis IO, Nicholson RI, Hurst HC. (1999). J Pathol 189: 514-520.
18. Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M. (2001). Oncogene 20: 3363-3375.
19. Haupt Y, Maya R, Kazaz A, Oren M. (1997). Nature 387: 296-299.
20. Hilger-Eversheim K, Moser M, Schorle H, Buettner R. (2000). Gene 260: 1-12.
21. Jiang JG, DeFrances MC, Machen J, Johnson C, Zarnegar R. (2000). Biochem Biophys Res Commun 272: 882-886.
22. Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM, Kosma VM. (1998). J Clin Oncol 16: 3584-3591.
23. Katsel PL, Greenstein RJ. (2001). J Biol Chem 276: 752-758.
24. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. (1992). Science 256: 827-830.
25. Kim HS, Hong SJ, LeDoux MS, Kim KS. (2001). J Neurochem 76: 280-294.
26. Kubbutat MH, Jones SN, Vousden KH. (1997). Nature 387: 299-303.
27. Leung KM, Po LS, Tsang FC, Siu WY, Lau A, Ho HT et al. (2002). Cancer Res 62: 4890-4893.
28. Lipponen P, Aaltomaa S, Kellokoski J, Ala-Opas M, Kosma V. (2000). Eur Urol 37: 573-578.
29. Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M et al. (2005). Oncogene 24: 637-649.
30. McPherson LA, Baichwal VR, Weigel RJ. (1997). Proc Natl Acad Sci USA 94: 4342-4347.
31. McPherson LA, Loktev AV, Weigel RJ. (2002). J Biol Chem 277: 45028-45033.
32. McPherson LA, Weigel RJ. (1999). Nucleic Acids Res 27: 4040-4049.
33. Mertens PR, Steinmann K, Alfonso-Jaume MA, En-Nia A, Sun Y, Lovett DH. (2002). J Biol Chem 277: 24875-24882.
34. Modugno M, Tagliabue E, Ardini E, Berno V, Galmozzi E, De Bortoli M et al. (2002). Oncogene 21: 7478-7487.
35. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F et al. (1995). Development 121: 2779-2788.
36. Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K et al. (1997). Genes Dev 11: 1938-1948.
37. Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T. (1998). Proc Natl Acad Sci USA 95: 13714-13719.
38. Oulad-Abdelghani M, Bouillet P, Chazaud C, Dolle P, Chambon P. (1996). Exp Cell Res 225: 338-347.
39. Pellikainen MJ, Pekola TT, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ et al. (2003). J Clin Pathol 56: 214-220.
40. Ren Y, Liao WS. (2001). J Biol Chem 13: 13.
41. Ropponen KM, Kellokoski JK, Lipponen PK, Pietilainen T, Eskelinen MJ, Alhava EM et al. (1999). Br J Cancer 81: 133-140.
42. Ropponen KM, Kellokoski JK, Pirinen RT, Moisio KI, Eskelinen MJ, Alhava EM et al. (2001). J Clin Pathol 54: 533-538.
43. Terui T, Murakami K, Takimoto R, Takahashi M, Takada K, Murakami T et al. (2003). Cancer Res 63: 8948-8954.
44. Vega FM, Sevilla A, Lazo PA. (2004). Mol Cell Biol 24: 10366-10380.
45. Wajapeyee N, Somasundaram K. (2003). J Biol Chem 278: 52093-52101.
46. Wang YH, Tsay YG, Tan BC, Lo WY, Lee SC. (2003). J Biol Chem 278: 25568-25576 Epub 2003 Apr 30.
47. West-Mays JA, Zhang J, Nottoli T, Hagopian-Donaldson S, Libby D, Strissel KJ et al. (1999). Dev Biol 206: 46-62.
48. Williams T, Admon A, Luscher B, Tjian R. (1988). Genes Dev 2: 1557-1569.
49. Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP. (2002). J Biol Chem 277: 47976-47979 Epub 2002 Oct 17.
50. Xu Y. (2003). Cell Death Differ 10: 400-403.
51. Zeng YX, Somasundaram K, el-Deiry WS. (1997). Nat Genet 15: 78-82.
52. Zhang J, Brewer S, Huang J, Williams T. (2003). Dev Biol 256: 127-145.
53. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP et al. (1996). Nature 381: 238-241.
54. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD. (2001). J Biol Chem 276: 40755-40760.